D72.11 Hypereosinophilic syndrome [HES]

Name of the Condition

• Common Name: Hypereosinophilic syndrome [HES]
• Medical Terms: Hypereosinophilic syndrome

Summary

Hypereosinophilic syndrome (HES) is a condition characterized by persistently elevated eosinophil levels in the blood and tissues, leading to organ damage. It is a diagnosis of exclusion, meaning other causes of eosinophilia must be ruled out. The condition can affect multiple organ systems, including the heart, lungs, skin, and nervous system.

Causes

The exact cause of HES is often unknown, though it may involve abnormal growth of eosinophils due to genetic mutations or dysregulated immune responses. Some cases are associated with clonal hematopoiesis, where eosinophils proliferate uncontrollably. In rare instances, it may be linked to underlying hematologic disorders.

Risk Factors

• Persistent eosinophilia without a known cause
• Family history of hematologic disorders
• Exposure to certain medications or environmental triggers (e.g., allergens)
• Underlying autoimmune or inflammatory conditions

Symptoms

• Fatigue and weakness
• Cough, shortness of breath, or chest pain (if lungs are involved)
• Skin rashes, itching, or nodules
• Abdominal pain, diarrhea, or nausea (if gastrointestinal tract is affected)
• Neurological symptoms (e.g., confusion, numbness) in severe cases
• Heart-related symptoms (e.g., palpitations, heart failure) if cardiac involvement occurs

Diagnosis

Diagnosis requires confirming persistent eosinophilia (typically >1,500 eosinophils per microliter for at least six months) and ruling out other causes (e.g., parasitic infections, allergies, or malignancies). Additional tests may include bone marrow biopsy, genetic testing, and imaging to assess organ involvement.

Treatment Options

Treatment focuses on reducing eosinophil levels and managing organ damage. Options may include corticosteroids, targeted therapies (e.g., tyrosine kinase inhibitors), or immunosuppressants. In severe cases, chemotherapy or stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies depending on organ involvement and response to treatment. Regular monitoring of eosinophil counts and organ function is essential. Long-term follow-up may be required to manage complications and adjust therapy.

Complications

• Organ damage (e.g., heart failure, lung fibrosis, gastrointestinal ulcers)
• Blood clots or thromboembolic events
• Neurological impairment
• Increased risk of infections due to immunosuppressive treatments

Lifestyle & Prevention

• Avoid known allergens or triggers
• Maintain regular medical check-ups to monitor eosinophil levels
• Follow prescribed treatments to prevent organ damage
• Report new or worsening symptoms promptly

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms such as chest pain, difficulty breathing, neurological changes, or signs of heart failure. Routine follow-up is necessary to manage chronic symptoms and adjust treatment.

Tips for Medical Coders

Document the persistence and severity of eosinophilia, organ involvement, and exclusion of other causes. Ensure clinical notes support the diagnosis of HES and specify any associated complications or treatments. Use this code only when criteria for hypereosinophilic syndrome are met.